NCT04941742View on ClinicalTrials.gov

The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Validation Phase)

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

December 22, 2021

Study Completion Date

December 22, 2021

Conditions

Eosinophilic Esophagitis

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors

lead

The University of Texas Health Science Center, Houston

OTHER

NCT04941742 - The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Validation Phase) | Biotech Hunter | Biotech Hunter